VANCOUVER, British Columbia, Aug. 1, 2007 (PRIME NEWSWIRE) -- TapImmune Inc. (OTCBB:TPIM), a biotechnology company specializing in the development of immunotherapeutics for cancer and vaccines for infectious diseases, opens new laboratory facilities and provides this update to shareholders.
